{"id":"W4398141543","doi":"10.1007/s10637-024-01444-0","title":"Correction to: CXCR2 antagonist navarixin in combination with pembrolizumab in select advanced solid tumors: a phase 2 randomized trial","year":2024,"lang":"en","type":"erratum","venue":"Investigational New Drugs","topic":"Cancer Mechanisms and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; Jewish General Hospital","funders":"","keywords":"Pembrolizumab; Medicine; Randomized controlled trial; Antagonist; Internal medicine; Oncology; Immunotherapy; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007511006,0.0005456876,0.00159269,0.001037764,0.00007084721,0.0001203824,0.0001525799,0.0003296978,0.0001796516],"category_scores_gemma":[0.0005267455,0.0004816165,0.0002236707,0.001368821,0.0001447186,0.0001782784,0.00003418655,0.001543557,0.00005168533],"about_ca_system_candidate":true,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001122855,"about_ca_system_score_gemma":0.006112507,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002042668,"about_ca_topic_score_gemma":0.001801488,"domain_scores_codex":[0.9965054,0.0002188261,0.001067375,0.0008384283,0.0009454712,0.0004244389],"domain_scores_gemma":[0.9985006,0.0003014848,0.0003633133,0.0002857952,0.0002063233,0.0003424539],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.6938348,0.0005877759,0.000003234989,0.0002222175,0.0001659331,0.0001630415,0.001949026,0.0002444896,0.0007888625,0.003690661,0.2937624,0.004587551],"study_design_scores_gemma":[0.9175545,0.002608855,0.00002462709,0.005627233,0.0001875244,0.00009604174,0.0001074728,0.009613131,0.001216108,0.01715399,0.04522751,0.0005830322],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.4480718,0.01254272,0.007172761,0.07376157,0.2908373,0.06938866,0.0008184201,0.002043131,0.0953636],"genre_scores_gemma":[0.3059161,0.0009334654,0.005618087,0.009733814,0.01456878,0.005724582,0.01531992,0.0007618515,0.6414234],"genre_candidate":"empirical","genre_consensus":null,"teacher_disagreement_score":0.5460598,"threshold_uncertainty_score":0.9997635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01090860077150055,"score_gpt":0.3068487250344997,"score_spread":0.2959401242629991,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}